Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The immunoglobulin E receptor: expression and regulation.

Edward R Conner1, Sarbjit S Saini

  • 1Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.

Current Allergy and Asthma Reports
|April 22, 2005
PubMed
Summary

Immunoglobulin E (IgE) interactions with its receptors are key in allergic diseases. Therapies targeting IgE receptors Fc epsilonRI and Fc epsilonRII (CD23) are advancing treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dupilumab in patients with cold urticaria: Results from a phase 3 trial.

The journal of allergy and clinical immunology. Global·2026
Same author

Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria.

The journal of allergy and clinical immunology. Global·2026
Same author

Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

JAMA dermatology·2026
Same author

Systemic Treatments for Chronic Spontaneous Urticaria: Anti-IgE and Beyond.

The journal of allergy and clinical immunology. In practice·2026
Same author

An opportunity to improve the quality of care for patients with chronic spontaneous urticaria: A reimagined 3-step real-world study protocol.

The journal of allergy and clinical immunology. Global·2026
Same author

Emerging IgE and non-IgE targeted therapies for chronic urticaria.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025

Area of Science:

  • Immunology
  • Allergy Research

Background:

  • Immunoglobulin E (IgE) and its receptor interactions are central to allergic disease pathogenesis.
  • Two main IgE receptors exist: high-affinity Fc epsilonRI and low-affinity Fc epsilonRII (CD23).

Purpose of the Study:

  • To review the roles of IgE receptors in allergic diseases.
  • To discuss current and emerging therapeutic strategies targeting these receptors.

Main Methods:

  • Review of existing literature on IgE receptor function and therapeutic development.
  • Analysis of the impact of IgE levels on Fc epsilonRI expression.

Main Results:

  • Fc epsilonRI exists as tetrameric or trimeric complexes with distinct expression and functions.
  • Serum IgE levels influence Fc epsilonRI expression, and therapies reducing IgE offer insights into receptor contributions.
  • Novel therapies targeting Fc epsilonRI signaling and Fc epsilonRII (CD23) are under development.

Conclusions:

  • Understanding IgE receptor interactions is crucial for managing allergic conditions.
  • Targeting Fc epsilonRI and Fc epsilonRII represents a promising avenue for new allergy treatments.

Related Experiment Videos